skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More


Show More

Show More

4 Total results for product and free and sample content found

Datamonitor Healthcare

Disappointing Translarna failure is an isolated event for CF pipeline

29 Mar 2017

PTC Therapeutics announced the failure of its ACT CF trial of Translarna (ataluren) in nonsense mutation cystic fibrosis (nmCF) patients, bringing a halt to any further planned developmental activities in the indication. Although there was a slight treatment effect, Translarna failed to significantly improve pulmonary measures compared to placebo.

Topic Comment Wire

Datamonitor Healthcare

Pfizer suspends the development of bococizumab

By Sita Indrakumar 03 Nov 2016

Pfizer has suspended the global development of its pipeline proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, bococizumab, due to a lack of predicted value.

Topic Approvals Comment Wire

Datamonitor Healthcare

Newly approved and late-phase biologics and eosinophilic asthma

24 May 2016

Newly approved and late-phase biologics and eosinophilic asthma

Data presented at ATS 2016 support the use of biologics in severe refractory eosinophilic asthma, and will inform the stringent formulary access policies expected to be implemented by payers for these high-cost therapies.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: